(H&J News, February 13, 2019) Yesterday we were pleased to hear that the early clinical department of H&J achieved excellent results in 2018. In the 2018, the CRO business contract of this department was about 33.12 million RMB, and the SMO business contract was about 4.5 million RMB. The total is about 37.62 million RMB.

This is a marvelous milestone. They are a well-deserved sharp knife unit of H&J.

No pains no gains. Such excellent results cannot be separated from the hard work and dedication of all the early clinical staff! In this regard, all our family members of H&J warmly congratulate them and pay high tribute to them! You are the pride and example of the H&J staff!